Ivy Gourd (Coccinia grandis)

Coccinia grandis
Evidence Level
Limited
6 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Ivy gourd (Coccinia grandis, also listed as Coccinia indica and Coccinia cordifolia; called tindora in India and ken in Sri Lanka) is a climbing vine in the gourd family. Its young leaves, shoot tips and small green fruits are eaten as a vegetable across South and Southeast Asia, and the plant has a long traditional use for blood sugar in Ayurveda. It is sold as leaf powder and extracts. Three small placebo-controlled trials in South Asia, all in adults with newly diagnosed or poorly controlled blood sugar problems, reported better glucose readings over six weeks to three months, and a single-meal study in healthy adults found a smaller blood sugar rise after a glucose drink. Lab work points to leaf flavonoids that slow carbohydrate-digesting enzymes. It can add to the effect of glucose-lowering medication, so anyone taking such drugs should involve their prescriber.

Studied Dose Human trials used 500 mg/day of an herbal formulation or 1 g/day of an alcoholic herb extract for about 3 months, a leaf preparation for 6 weeks, or 20 g of raw leaves eaten once with a meal. No dose is established for people with normal blood sugar.
Active Compound Leaf flavonoid glycosides (rutin, kaempferol 3-O-rutinoside and related quercetin and kaempferol glycosides) shown to inhibit alpha-glucosidase in lab tests; fruit pectin studied in rats, and cucurbitane-type triterpenoids (coccinosides A, B and C) isolated from a fruit extract that lowered glucose in diabetic rats. No single marker compound is standardized across products.

Benefits

Fasting glucose and HbA1c support over three months

In two double-blind placebo-controlled trials in adults with newly diagnosed type 2 diabetes, ivy gourd preparations (1 g/day extract or a 500 mg/day herbal formulation) for about three months lowered fasting glucose and HbA1c more than placebo. Both trials were small and single-center, and the results apply only to that population.

Smaller blood sugar rise after a glucose drink

In a single-meal study, 122 healthy adults ate 20 g of raw ivy gourd leaves or a look-alike leaf before a 75 g glucose drink. Blood sugar one and two hours later was lower in the ivy gourd group, by about 20 and 11 mg/dL on average. Fasting levels did not differ. This is a one-time marker test, not a long-term result.

Glucose tolerance with a six-week leaf preparation

In an early double-blind trial in 32 adults with uncontrolled adult-onset diabetes, 10 of 16 people given a leaf preparation for six weeks showed a marked improvement in their glucose tolerance test, compared with none of 16 given a dummy preparation. The abstract reports only this count, not the size of the glucose change.

Triglyceride changes alongside glucose markers

In the three-month trial of a 500 mg/day herbal formulation in adults with newly diagnosed type 2 diabetes, triglycerides and VLDL cholesterol fell more than with placebo, while other lipid measures did not differ. A separate 90-day trial of a 1 g/day extract found no significant change in blood lipids.

Absorbable calcium from the leaves as a vegetable

In a crossover study in 19 healthy women, about 48% of the calcium in a meal of ivy gourd leaves was absorbed, compared with about 55% from milk. Fiber, oxalate and phytate in the leaves lowered absorption somewhat, but the leaves still delivered a useful share of their calcium as a food.

Carbohydrate enzyme inhibition in lab tests

Flavonoid glycosides isolated from ivy gourd leaves, including rutin and kaempferol glycosides, inhibited alpha-glucosidase, an enzyme that breaks down carbohydrates, in test-tube assays. This is laboratory work only; enzyme inhibition was not measured in people.

Mechanism of action

1

Alpha-glucosidase inhibition by leaf flavonoids

In lab assays, seven flavonoid glycosides isolated from the leaves slowed alpha-glucosidase, the gut enzyme that splits carbohydrates into absorbable sugars. Slower carbohydrate breakdown would be expected to blunt the rise in blood sugar after a meal. This is a proposed explanation from test-tube work, not a measured effect in people.

2

Lower liver glucose-6-phosphatase activity

In rats, an ethanol leaf extract lowered blood glucose and reduced the starvation-induced rise in glucose-6-phosphatase, the liver enzyme that releases glucose into the blood. A small human study in diabetic patients reported that raised plasma glucose-6-phosphatase activity moved back toward normal after six weeks of an extract given at a very high body-weight dose.

3

Liver glycogen storage from fruit pectin

In normal rats, pectin isolated from ivy gourd fruit lowered blood glucose, raised liver glycogen and increased glycogen synthase activity while lowering phosphorylase activity, which suggests more glucose was stored in the liver. These are animal findings at a high dose and have not been tested in people.

Clinical trials

1
Three-month herbal formulation trial in newly diagnosed type 2 diabetes
PubMed

Randomized, double-blind, placebo-controlled trial of a newly developed herbal formulation of Coccinia grandis (the group's preclinical work used an aqueous leaf extract), 500 mg once daily for three months versus placebo, at a teaching hospital in Galle, Sri Lanka. Funded by the National Research Council Sri Lanka (grant 17-029). (Wasana et al. 2021, Phytomedicine)

158 adults with newly diagnosed type 2 diabetes (mean age about 45), 79 per group; 145 completed.

Compared with placebo, HbA1c fell more (mean change 0.65 vs 0.08 percentage points, p<0.001), as did fasting plasma glucose, insulin, fructosamine, HOMA-IR, triglycerides and VLDL cholesterol (all p<0.001). Other measured outcomes did not differ from placebo. The abstract does not name a single primary outcome. Kidney, liver and blood counts and blood pressure stayed within normal ranges.

2
90-day extract trial in newly detected type 2 diabetes
PubMed

Double-blind, placebo-controlled randomized trial of 1 g/day of an alcoholic extract of Coccinia cordifolia (plant part not stated in the abstract) for 90 days, with standard diet and activity advice for all. Registered as NCT00502008; lead sponsor St. John's Research Institute with Gencor Pacific Group listed as an industry collaborator. The registered primary outcome was fasting and postprandial glucose and HbA1c at 90 days. (Kuriyan et al. 2008, Diabetes Care)

60 adults aged 35 to 60 with newly detected type 2 diabetes needing only lifestyle treatment (fasting glucose 110 to 180 mg/dL), not on glucose-lowering drugs.

Fasting glucose, postprandial glucose and HbA1c fell significantly more in the extract group than with placebo; at day 90 fasting and postprandial glucose in the extract group were 16% and 18% lower. Serum lipids did not change significantly.

3
Single-meal raw leaf glucose tolerance test in healthy adults
PubMed

Double-blind trial randomized by coin toss at two hospitals in Matara, Sri Lanka. After an overnight fast, participants ate 20 g of raw Coccinia grandis leaves with coconut and salt, or the same meal made with Erythrina indica leaves as placebo, then drank 75 g of glucose. Authors declared no conflicts. (Munasinghe et al. 2011, Exp Diabetes Res)

122 healthy adults aged 18 to 55, 61 per group; groups differed in sex balance.

Blood sugar was lower in the ivy gourd group at one hour (mean difference 20.2 mg/dL, 95% CI 4.81 to 35.5) and two hours (11.46 mg/dL, 95% CI 1.03 to 21.9). Fasting blood sugar did not differ (p=0.31). No hypoglycemia symptoms such as sweating or tremor were reported. This is a single-meal marker test.

4
Six-week leaf preparation trial in uncontrolled adult-onset diabetes
PubMed

Double-blind controlled trial of a preparation made from Coccinia indica leaves versus a dummy preparation for six weeks. (Azad Khan et al. 1979, Bangladesh Med Res Counc Bull)

32 adults with uncontrolled maturity-onset diabetes, 16 per group.

10 of 16 people in the leaf group showed a marked improvement in glucose tolerance versus none of 16 in the dummy group (p<0.001). The abstract does not report the dose or the size of the glucose change.

5
Six-week enzyme study in diabetic patients
PubMed

Small clinical study of a dried Coccinia indica extract given at 500 mg per kg body weight daily for six weeks, measuring plasma enzymes before and after treatment. No placebo group is described in the abstract. (Kamble et al. 1998, Indian J Med Sci)

30 people with diabetes of varying severity.

In severe diabetes, raised glucose-6-phosphatase and lactate dehydrogenase and reduced lipoprotein lipase activity moved back toward normal after treatment; mild diabetes showed no enzyme changes. The body-weight dose is far above the amounts used in later trials.

6
Calcium absorption from ivy gourd leaves in healthy women
PubMed

Three-way randomized crossover study comparing calcium absorption from ivy gourd leaves, winged bean pods and milk (about 100 mg calcium each, labeled with 44Ca) eaten with rice. (Charoenkiatkul et al. 2008, J Food Sci)

19 healthy women aged 20 to 45 in Thailand.

Fractional calcium absorption was 0.476 from ivy gourd, 0.391 from winged bean and 0.552 from milk; both vegetables were significantly lower than milk, partly due to phytate, oxalate and fiber.

Side effects and drug interactions

Common Potential side effects

Low blood sugar is the main concern. In a survey of 1,000 Sri Lankans with type 2 diabetes, ivy gourd was among the non-prescribed native foods patients linked to hypoglycemic episodes. The risk adds up with glucose-lowering medication.
In a three-month trial at 500 mg/day, kidney and liver tests, blood counts and blood pressure stayed within normal ranges.
In a single-meal study of raw leaves, nausea and headache were uncommon and occurred at similar rates with the placebo leaf.
Safety in pregnancy and breastfeeding has not been studied at supplement doses.
In male mice, a leaf extract given for 35 days lowered testosterone and suppressed sperm production and fertility, which recovered after stopping. Whether this applies to people is unknown, so men trying to conceive may prefer to avoid concentrated extracts.
Long-term safety of concentrated extracts beyond three months has not been studied.

Important Drug interactions

Insulin and sulfonylureas: blood sugar may fall further than expected. Monitor glucose and talk to the prescriber before use.
Metformin, GLP-1 agonists, SGLT2 inhibitors and other glucose-lowering drugs: possible additive lowering of blood sugar; monitor and discuss with the prescriber.
Acarbose and miglitol: lab tests show ivy gourd leaf flavonoids inhibit the same alpha-glucosidase enzyme, so effects could overlap; this has not been studied in people.
Other blood-sugar herbs such as bitter melon and gymnema: combining them may add to the glucose-lowering effect.

Frequently asked questions about Ivy Gourd (Coccinia grandis)

What is ivy gourd?

Ivy gourd (Coccinia grandis) is a climbing vine in the gourd family. Its small green fruits, young leaves and shoot tips are eaten as a vegetable in India, Sri Lanka, Thailand and other parts of Asia. As a supplement it is sold as dried leaf powder or as leaf or whole-herb extracts, mainly for blood sugar support.

Does ivy gourd affect blood sugar?

Small placebo-controlled trials in South Asia found better fasting glucose, HbA1c or glucose tolerance after six weeks to three months, but they enrolled adults with newly diagnosed or poorly controlled high blood sugar. A one-time study in healthy adults found a smaller rise after a glucose drink. It is not a treatment and must not replace prescribed care.

How much ivy gourd was used in studies?

Trials used 500 mg a day of an herbal formulation or 1 g a day of an extract for about three months, or 20 g of raw leaves eaten once with a meal. Products differ in plant part and extract strength, so follow the label. No dose is established for people with normal blood sugar.

Is ivy gourd safe to take with medication?

It is eaten widely as a food, and liver and kidney tests stayed within normal ranges in a three-month trial. The main risk is low blood sugar when it is combined with insulin, sulfonylureas or other glucose-lowering drugs; patients in Sri Lanka have linked it to hypoglycemic episodes. Check with your prescriber and monitor glucose before adding it.

What is Ivy Gourd used for?

Ivy Gourd is researched primarily for Metabolic Health. In two double-blind placebo-controlled trials in adults with newly diagnosed type 2 diabetes, ivy gourd preparations (1 g/day extract or a 500 mg/day herbal formulation) for about three months lowered fasting glucose and HbA1c more than pla…

Is Ivy Gourd safe, and does it have side effects?

Side effects and cautions reported for Ivy Gourd include: Low blood sugar is the main concern. In a survey of 1,000 Sri Lankans with type 2 diabetes, ivy gourd was among the non-prescribed native foods patients linked to hypoglycemic episodes. The risk adds up with glucose-lowering medication. It may also interact with some medications. Ivy Gourd is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Ivy Gourd interact with any medications?

Possible interactions include: Insulin and sulfonylureas: blood sugar may fall further than expected. Monitor glucose and talk to the prescriber before use. Metformin, GLP-1 agonists, SGLT2 inhibitors and other glucose-lowering drugs: possible additive lowering of blood sugar; monitor and discuss with the pres… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Ivy Gourd?

NutraSmarts rates the evidence for Ivy Gourd as Limited (2 out of 5). It is backed by 6 study summaries and 14 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(14 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Wasana KGP, Attanayake AP, Weerarathna TP, Jayatilaka KAPW. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial. Phytomedicine. 2021;81:153431. doi: 10.1016/j.phymed.2020.153431.PubMedUsed to support: Randomized double-blind placebo-controlled trial in 158 adults with newly diagnosed type 2 diabetes in Sri Lanka (145 completed). A 500 mg/day herbal formulation of Coccinia grandis for three months lowered HbA1c, fasting plasma glucose, insulin, fructosamine, HOMA-IR, triglycerides and VLDL cholesterol more than placebo (p<0.001); other outcomes did not differ. Safety tests stayed in normal ranges. Funded by the National Research Council Sri Lanka.
  2. Kuriyan R, Rajendran R, Bantwal G, Kurpad AV. Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care. 2008;31(2):216-20. doi: 10.2337/dc07-1591.PubMedUsed to support: Double-blind placebo-controlled randomized trial in 60 adults with newly detected type 2 diabetes managed by lifestyle alone. 1 g/day of an alcoholic Coccinia cordifolia extract for 90 days lowered fasting glucose, postprandial glucose and HbA1c more than placebo; fasting and postprandial glucose fell 16% and 18% in the extract group. Lipids did not change. Registered as NCT00502008, with Gencor Pacific Group listed as an industry collaborator.
  3. Munasinghe MA, Abeysena C, Yaddehige IS, Vidanapathirana T, Piyumal KP. Blood sugar lowering effect of Coccinia grandis (L.) J. Voigt: path for a new drug for diabetes mellitus. Exp Diabetes Res. 2011;2011:978762. doi: 10.1155/2011/978762.PubMedUsed to support: Double-blind single-meal trial in 122 healthy adults. Eating 20 g of raw Coccinia grandis leaves before a 75 g glucose drink led to lower blood sugar at one hour (mean difference 20.2 mg/dL) and two hours (11.46 mg/dL) than a placebo leaf meal; fasting values did not differ. Authors declared no conflicts of interest.
  4. Azad Khan AK, Akhtar S, Mahtab H. Coccinia indica in the treatment of patients with diabetes mellitus. Bangladesh Med Res Counc Bull. 1979;5(2):60-6.PubMedUsed to support: Six-week double-blind controlled trial of a leaf preparation in adults with uncontrolled maturity-onset diabetes. 10 of 16 treated patients showed marked improvement in glucose tolerance versus none of 16 on a dummy preparation (p<0.001).
  5. Kamble SM, Kamlakar PL, Vaidya S, Bambole VD. Influence of Coccinia indica on certain enzymes in glycolytic and lipolytic pathway in human diabetes. Indian J Med Sci. 1998;52(4):143-6.PubMedUsed to support: Small study in 30 diabetic patients given a dried Coccinia indica extract at 500 mg/kg body weight for six weeks. In severe diabetes, raised glucose-6-phosphatase and lactate dehydrogenase and low lipoprotein lipase activity moved toward normal after treatment; mild diabetes showed no enzyme changes.
  6. Charoenkiatkul S, Kriengsinyos W, Tuntipopipat S, Suthutvoravut U, Weaver CM. Calcium absorption from commonly consumed vegetables in healthy Thai women. J Food Sci. 2008;73(9):H218-21. doi: 10.1111/j.1750-3841.2008.00949.x.PubMedUsed to support: Randomized crossover study in 19 healthy women. Fractional calcium absorption was 0.476 from ivy gourd leaves, 0.391 from winged bean pods and 0.552 from milk; the vegetables were lower than milk, partly because of phytate, oxalate and fiber, but still provided well-absorbed calcium.
  7. Dissanayake HA, Keerthisena GSP, Gamage KKK, Liyanage JH, Ihalagama IRHS, Wijetunga WMUA, Tillekaratne TAD, Katulanda GW, Katulanda P. Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka. BMC Endocr Disord. 2018;18(1):35. doi: 10.1186/s12902-018-0264-0.PubMedUsed to support: Interview survey of 1,000 Sri Lankan outpatients with type 2 diabetes. Non-prescribed native foods accounted for hypoglycemia in 16.9% of affected patients, and Coccinia grandis was named in 6.8% of those cases, alongside bitter melon and other plants.
  8. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26(4):1277-94. doi: 10.2337/diacare.26.4.1277.PubMedUsed to support: Systematic review of 108 trials of herbs and supplements in diabetes or impaired glucose tolerance. It found insufficient evidence for firm conclusions on any single herb, but said the best evidence from adequately designed randomized trials at that time was for Coccinia indica and American ginseng.
  9. Astiti MA, Jittmittraphap A, Leaungwutiwong P, Chutiwitoonchai N, Pripdeevech P, Mahidol C, Ruchirawat S, Kittakoop P. LC-QTOF-MS/MS Based Molecular Networking Approach for the Isolation of α-Glucosidase Inhibitors and Virucidal Agents from Coccinia grandis (L.) Voigt. Foods. 2021;10(12):3041. doi: 10.3390/foods10123041.PubMedUsed to support: Laboratory study. Notes that ivy gourd leaves and fruits are eaten as a vegetable. Seven flavonoid glycosides isolated from the leaves, including rutin and kaempferol 3-O-rutinoside, inhibited alpha-glucosidase 4.4 to 10.3 times more potently than acarbose in vitro.
  10. Hossain MZ, Shibib BA, Rahman R. Hypoglycemic effects of Coccinia indica: inhibition of key gluconeogenic enzyme, glucose-6-phosphatase. Indian J Exp Biol. 1992;30(5):418-20.PubMedUsed to support: Animal study. An ethanol extract of Coccinia indica leaves given orally lowered blood glucose by 21% in fed and 24% in starved rats and reduced the starvation-induced rise in liver glucose-6-phosphatase activity by 19%.
  11. Kumar GP, Sudheesh S, Vijayalakshmi NR. Hypoglycaemic effect of Coccinia indica: mechanism of action. Planta Med. 1993;59(4):330-2. doi: 10.1055/s-2006-959693.PubMedUsed to support: Animal study. Pectin isolated from Coccinia indica fruit, given to normal rats at 200 mg/100 g body weight daily, lowered blood glucose, increased liver glycogen and glycogen synthase activity, and reduced phosphorylase activity.
  12. Kaushik U, Aeri V, Showkat RM, Ali M. Cucurbitane-Type Triterpenoids from the Blood Glucose-Lowering Extracts of Coccinia indica and Momordica balsamina Fruits. Pharmacogn Mag. 2017;13(Suppl 1):S115-S121. doi: 10.4103/0973-1296.203991.PubMedUsed to support: Animal and chemistry study. A chloroform extract of Coccinia indica fruit at 250 mg/kg for a week lowered fasting blood glucose in diabetic rats, and three cucurbitane-type triterpenoids (coccinosides A, B and C) were isolated from it.
  13. Verma HP, Singh SK. Antifertility efficacy of Coccinia indica in male mice and its possible mechanisms of action on spermatogenesis. Gen Comp Endocrinol. 2017;241:89-99. doi: 10.1016/j.ygcen.2016.05.007.PubMedUsed to support: Animal study. A 50% ethanol leaf extract of Coccinia indica given orally to male mice at 200 or 500 mg/kg daily for 35 days lowered serum testosterone, harmed sperm parameters and suppressed fertility without signs of liver or kidney toxicity; all measures recovered to control levels 56 days after treatment stopped.
  14. Bunkrongcheap R, Hutadilok-Towatana N, Noipha K, Wattanapiromsakul C, Inafuku M, Oku H. Ivy gourd (Coccinia grandis L. Voigt) root suppresses adipocyte differentiation in 3T3-L1 cells. Lipids Health Dis. 2014;13:88. doi: 10.1186/1476-511X-13-88.PubMedUsed to support: Cell culture study. Of ethanol extracts of ivy gourd leaf, stem and root, only the root extract suppressed fat cell differentiation in 3T3-L1 cells, with lower expression of PPAR-gamma and C/EBP-alpha. The leaf and stem extracts did not show this effect.